Staff Scientist, Integrative Neurobiology Section
ContactTriad Technology Center
333 Cassell Drive
Baltimore, MD 21224
Postdoctoral research training, National Institute on Drug Abuse. Behavioral Neuroscience Research Branch, 2005-2010.
Postgraduate research training, Institute of Cellular Physiology, Autonomous National University of Mexico, 2004.
Ph. D. in Psychology, Faculty of Psychology, Autonomous National University of Mexico, 2004.
Postgraduate research training, Faculty of Medicine, University of Santiago de Compostela, Spain, 1999-2000, 2003-2004.
Master’s in Psychobiology, Faculty of Psychology, Autonomous National University of Mexico, 1999.
Bachelor’s Degree in Psychology, Autonomous National University of Mexico, 1997.
Dr. Quiroz earned his bachelor’s, master’s and Ph. D. degrees from the National Autonomous University of Mexico, in Mexico City. He further conducted postgraduate research on the University of Santiago de Compostela, Spain, and on the Institute of Cellular Physiology, in Mexico City. He joined NIDA in 2005 and has since worked on the discovery and characterization of new cellular receptor complexes and on uncovering long-lasting changes in the function of these cellular receptors following the exposure to drugs of abuse.
Dr. Quiroz doctoral research on the field of over-reinforced learning and memory met seamlessly with the field of substance abuse, which could arguably be viewed as a set of learned experiences with cues so salient that cannot be forgotten and are persistently recalled. Dr. Quiroz work is inspired by the search for the elusive biological substrates of overly reinforced experiences, for which receptor-receptor interactions as modulatory mechanisms in neuronal signaling may play an important role.
At NIDA, Dr. Quiroz has made several developments in the field of in vivo neurochemistry, specifically creating a technique that makes possible the delivery of large synthetic peptides into the living brain while allowing simultaneous sampling for the determination of neurotransmitter release within that same brain region. This innovation has made possible the application of synthetic peptides that are aimed at probing the molecular mechanism in the living brain that is involved in the modulation of receptor heteromeric complexes. He also has developed an implantable device that allows optogenetic stimulation of nerve terminals and simultaneous sampling of neurotransmitter release, a contribution used successfully to establish the functional circuitry on integrative brain regions.
As a scientist at NIDA, Dr. Quiroz works towards the discovery of biological mechanisms that reveal medicinal targets to help reduce the adverse consequences of the exposure to substances of abuse. His long-term research goal is to contribute to the understanding of the biological and behavioral factors contributing to initiation, maintenance, and elimination of drug abuse and addiction, and to translate this knowledge into improved strategies for eliminating the harmful consequences for the individual and for society caused by drug abuse and addiction.
In: Ann Neurol, vol. 82, no. 6, pp. 951–960, 2017, ISSN: 1531-8249 (Electronic); 0364-5134 (Linking).
In: J Neurosci, vol. 37, no. 5, pp. 1176–1186, 2017, ISSN: 1529-2401 (Electronic); 0270-6474 (Linking).
In: Neuropharmacology, vol. 111, pp. 160–168, 2016, ISSN: 1873-7064 (Electronic); 0028-3908 (Linking).
In: J Neurosci, vol. 36, no. 3, pp. 851–859, 2016, ISSN: 1529-2401 (Electronic); 0270-6474 (Linking).
In: J Neurosci, vol. 35, no. 17, pp. 6639–6653, 2015, ISSN: 1529-2401 (Electronic); 0270-6474 (Linking).